• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

康复个体对新冠病毒的免疫记忆程度存在异质性。

Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals.

作者信息

Mazzoni Alessio, Maggi Laura, Capone Manuela, Vanni Anna, Spinicci Michele, Salvati Lorenzo, Tekle Kiros Seble, Semeraro Roberto, Pengue Luca, Colao Maria Grazia, Magi Alberto, Rossolini Gian Maria, Liotta Francesco, Cosmi Lorenzo, Bartoloni Alessandro, Annunziato Francesco

机构信息

Department of Experimental and Clinical Medicine University of Florence Florence Italy.

Infectious and Tropical Diseases Unit Careggi University Hospital Florence Italy.

出版信息

Clin Transl Immunology. 2021 May 6;10(5):e1281. doi: 10.1002/cti2.1281. eCollection 2021.

DOI:10.1002/cti2.1281
PMID:33976879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8101693/
Abstract

OBJECTIVE

Although the adaptive immune response to SARS-CoV-2 has been characterised in the acute and early convalescent phase of the disease, few studies explore whether natural infection elicits long-lasting immunological memory in recovered individuals. In this work, we aimed to assess the maintenance of immunological memory to SARS-CoV-2.

METHODS

We evaluated the long-term virus-specific cellular and humoral immune response in the members of an Italian Serie A football team, who experienced a cluster of COVID-19 in March 2020, which was strictly evaluated in the following months.

RESULTS

Our results highlight a heterogeneous magnitude of immunological memory at 5 months after infection. Indeed, 20% of the subjects displayed a weak cellular and humoral memory to SARS-CoV-2, suggesting that they may be at higher risk of reinfection. In addition, a history of symptomatic COVID-19 was associated with higher levels of SARS-CoV-2-reactive CD4 T cells and specific antibody levels than in asymptomatic individuals.

CONCLUSION

Collectively, these data demonstrate that immunity to SARS-CoV-2 is maintained five months postinfection even if the magnitude of response is heterogeneous among individuals. This finding suggests that some COVID-19-recovered subjects may benefit from vaccination.

摘要

目的

尽管对SARS-CoV-2的适应性免疫反应已在该疾病的急性期和早期恢复期得到了表征,但很少有研究探讨自然感染是否会在康复个体中引发持久的免疫记忆。在这项研究中,我们旨在评估对SARS-CoV-2免疫记忆的维持情况。

方法

我们评估了一支意大利甲级足球队队员的长期病毒特异性细胞免疫和体液免疫反应,这些队员在2020年3月经历了一群人感染新冠病毒的情况,并在接下来的几个月里进行了严格评估。

结果

我们的结果突出了感染后5个月免疫记忆的异质性。事实上,20%的受试者对SARS-CoV-2表现出较弱的细胞免疫和体液免疫记忆,这表明他们可能有更高的再次感染风险。此外,有症状的新冠病毒感染病史与无症状个体相比,SARS-CoV-2反应性CD4 T细胞水平和特异性抗体水平更高。

结论

总体而言,这些数据表明,即使个体之间的反应程度存在异质性,感染SARS-CoV-2后的免疫力在感染后5个月仍得以维持。这一发现表明,一些新冠病毒康复者可能会从疫苗接种中受益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfc/8101693/e337ab61d113/CTI2-10-e1281-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfc/8101693/5a21314c5dee/CTI2-10-e1281-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfc/8101693/e5caa57e38e4/CTI2-10-e1281-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfc/8101693/ee144869229c/CTI2-10-e1281-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfc/8101693/e337ab61d113/CTI2-10-e1281-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfc/8101693/5a21314c5dee/CTI2-10-e1281-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfc/8101693/e5caa57e38e4/CTI2-10-e1281-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfc/8101693/ee144869229c/CTI2-10-e1281-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfc/8101693/e337ab61d113/CTI2-10-e1281-g001.jpg

相似文献

1
Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals.康复个体对新冠病毒的免疫记忆程度存在异质性。
Clin Transl Immunology. 2021 May 6;10(5):e1281. doi: 10.1002/cti2.1281. eCollection 2021.
2
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies.SARS-CoV-2 感染和疫苗接种引发具有增强策略意义的长寿 B 和 CD4+ T 淋巴细胞。
J Clin Invest. 2022 Mar 15;132(6). doi: 10.1172/JCI157990.
3
Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection.感染后 1 年的 COVID-19 恢复期患者对 SARS-CoV-2 的免疫记忆。
J Allergy Clin Immunol. 2021 Dec;148(6):1481-1492.e2. doi: 10.1016/j.jaci.2021.09.008. Epub 2021 Sep 15.
4
Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.评估 SARS-CoV-2 免疫在康复期儿童和青少年中的作用。
Front Immunol. 2021 Dec 17;12:797919. doi: 10.3389/fimmu.2021.797919. eCollection 2021.
5
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19.首剂 mRNA 疫苗接种足以使 COVID-19 康复者重新激活对 SARS-CoV-2 的免疫记忆。
J Clin Invest. 2021 Jun 15;131(12). doi: 10.1172/JCI149150.
6
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.无症状 COVID-19 患者的细胞介导和体液适应性免疫应答低于有症状 COVID-19 患者。
Eur J Immunol. 2020 Dec;50(12):2013-2024. doi: 10.1002/eji.202048915. Epub 2020 Nov 9.
7
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.COVID-19 恢复期患者体内 SARS-CoV-2 抗体动态变化和 B 细胞记忆应答特征。
Clin Microbiol Infect. 2021 Sep;27(9):1349.e1-1349.e6. doi: 10.1016/j.cmi.2021.05.008. Epub 2021 May 8.
8
Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.SARS-CoV-2 感染后长达 9 个月的稳健且具有功能性的免疫记忆:一项东南亚纵向队列研究。
Front Immunol. 2022 Feb 3;13:817905. doi: 10.3389/fimmu.2022.817905. eCollection 2022.
9
Surviving Older Patients Show Preserved Cellular and Humoral Immunological Memory Several Months After SARS-CoV-2 Infection.感染 SARS-CoV-2 数月后,存活的老年患者表现出细胞和体液免疫记忆的保留。
J Gerontol A Biol Sci Med Sci. 2022 Jan 7;77(1):33-40. doi: 10.1093/gerona/glab206.
10
Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel.COVID-19 与疫苗接种后的免疫反应:医务人员随访研究超过 1 年。
Infection. 2022 Apr;50(2):439-446. doi: 10.1007/s15010-021-01703-9. Epub 2021 Sep 25.

引用本文的文献

1
Prepandemic levels of cytokines and immunoglobulins and risk of SARS-CoV-2 infection and COVID-19 in the general population of Barcelona.巴塞罗那普通人群中细胞因子和免疫球蛋白的疫情前水平以及感染新冠病毒和患新冠肺炎的风险
Front Public Health. 2025 Aug 20;13:1548456. doi: 10.3389/fpubh.2025.1548456. eCollection 2025.
2
Modelling and investigating memory immune responses in infectious disease. Application to influenza a virus and sars-cov-2 reinfections.传染病记忆免疫反应的建模与研究。在甲型流感病毒和新冠病毒再感染中的应用。
Infect Dis Model. 2024 Oct 9;10(1):163-188. doi: 10.1016/j.idm.2024.09.009. eCollection 2025 Mar.
3

本文引用的文献

1
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.无症状 SARS-CoV-2 感染中具有高功能的病毒特异性细胞免疫应答。
J Exp Med. 2021 May 3;218(5). doi: 10.1084/jem.20202617.
2
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.对感染后长达 8 个月的 SARS-CoV-2 进行免疫记忆评估。
Science. 2021 Feb 5;371(6529). doi: 10.1126/science.abf4063. Epub 2021 Jan 6.
3
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.轻度 COVID-19 后,SARS-CoV-2 特异性免疫记忆仍具有功能性。
Recurring SARS-CoV-2 variants: an update on post-pandemic, co-infections and immune response.
反复出现的 SARS-CoV-2 变体:后疫情时代、合并感染和免疫反应的最新进展。
Nanotheranostics. 2024 Feb 25;8(2):247-269. doi: 10.7150/ntno.91910. eCollection 2024.
4
Impact of Vaccination and Nonpharmaceutical Interventions With Possible COVID-19 Viral Evolutions Using an Agent-Based Simulation.基于主体模拟的疫苗接种和非药物干预对可能的新冠病毒进化的影响
AJPM Focus. 2023 Oct 10;3(1):100155. doi: 10.1016/j.focus.2023.100155. eCollection 2024 Feb.
5
Acute and long-term immune responses to SARS-CoV-2 infection in unvaccinated children and young adults with inborn errors of immunity.未接种疫苗的先天性免疫缺陷儿童和年轻人中对 SARS-CoV-2 感染的急性和长期免疫反应。
Front Immunol. 2023 Jan 20;14:1084630. doi: 10.3389/fimmu.2023.1084630. eCollection 2023.
6
Individual blood concentrations of persistent organic pollutants and chemical elements, and COVID-19: A prospective cohort study in Barcelona.个体血液中持久性有机污染物和化学元素浓度与 COVID-19 的关系:巴塞罗那的一项前瞻性队列研究。
Environ Res. 2023 Apr 15;223:115419. doi: 10.1016/j.envres.2023.115419. Epub 2023 Feb 4.
7
SARS-CoV-2-specicific humoral immunity in convalescent patients with mild COVID-19 is supported by CD4 T-cell help and negatively correlated with Alphacoronavirus-specific antibody titer.SARS-CoV-2 特异性体液免疫在轻症 COVID-19 恢复期患者中得到 CD4 T 细胞辅助的支持,与 Alphacoronavirus 特异性抗体滴度呈负相关。
Immunol Lett. 2022 Dec;251-252:38-46. doi: 10.1016/j.imlet.2022.09.007. Epub 2022 Sep 27.
8
SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron.SARS-CoV-2 刺突蛋白特异性 CD4+ T 细胞反应针对包括奥密克戎在内的关注变异株具有保守性。
Front Immunol. 2022 Jan 26;13:801431. doi: 10.3389/fimmu.2022.801431. eCollection 2022.
9
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies.SARS-CoV-2 感染和疫苗接种引发具有增强策略意义的长寿 B 和 CD4+ T 淋巴细胞。
J Clin Invest. 2022 Mar 15;132(6). doi: 10.1172/JCI157990.
10
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition).流式细胞术和细胞分选在免疫学研究中的应用指南(第三版)。
Eur J Immunol. 2021 Dec;51(12):2708-3145. doi: 10.1002/eji.202170126. Epub 2021 Dec 7.
Cell. 2021 Jan 7;184(1):169-183.e17. doi: 10.1016/j.cell.2020.11.029. Epub 2020 Nov 23.
4
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.正交 SARS-CoV-2 血清学检测可用于监测低流行社区,并揭示持久的体液免疫。
Immunity. 2020 Nov 17;53(5):925-933.e4. doi: 10.1016/j.immuni.2020.10.004. Epub 2020 Oct 14.
5
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.无症状 COVID-19 患者的细胞介导和体液适应性免疫应答低于有症状 COVID-19 患者。
Eur J Immunol. 2020 Dec;50(12):2013-2024. doi: 10.1002/eji.202048915. Epub 2020 Nov 9.
6
Genomic evidence for reinfection with SARS-CoV-2: a case study.基因组证据表明 SARS-CoV-2 再次感染:一项案例研究。
Lancet Infect Dis. 2021 Jan;21(1):52-58. doi: 10.1016/S1473-3099(20)30764-7. Epub 2020 Oct 12.
7
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.COVID-19 患者中针对 SARS-CoV-2 刺突蛋白受体结合域的人抗体反应的持久性和衰减。
Sci Immunol. 2020 Oct 8;5(52). doi: 10.1126/sciimmunol.abe0367.
8
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.急性 COVID-19 患者中针对 SARS-CoV-2 的抗原特异性适应性免疫反应,及其与年龄和疾病严重程度的关联。
Cell. 2020 Nov 12;183(4):996-1012.e19. doi: 10.1016/j.cell.2020.09.038. Epub 2020 Sep 16.
9
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.无症状或轻症 COVID-19 康复者体内具有强大的 T 细胞免疫。
Cell. 2020 Oct 1;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017. Epub 2020 Aug 14.
10
Seasonal coronavirus protective immunity is short-lasting.季节性冠状病毒的保护免疫作用是短暂的。
Nat Med. 2020 Nov;26(11):1691-1693. doi: 10.1038/s41591-020-1083-1. Epub 2020 Sep 14.